What to Know About 2 New Gene Therapies for Sickle Cell Disease
Casgevy and Lyfgenia were both approved by the FDA to treat sickle cell disease. Both treatments also cost millions of dollars.
Source: everydayhealth.com
Markus Mapara News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Markus Mapara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Markus Mapara Today - Breaking & Trending Today
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.
Source: nbcchicago.com
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.
Source: nbclosangeles.com
FDA Approves First CRISPR Treatment in U.S.
Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.
Source: time.com